Albion Financial Group
- SEC CIK
- 0001054677
- Latest filing
- Jul 22, 2026
DFTX holding history
Definium Therapeutics, Inc. in every 13F filed by Albion Financial Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DFTX overviewAll 13F holders of DFTXFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −132−100.0% | Sold out | Holders |
| Q3 2024 | 132 | $752 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 132 | $952 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 132 | $1.24K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 132 | $484 | <0.1% | −191−59.1% | Reduced | Holders |
| Q3 2023 | 323 | $1.01K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 323 | $1.15K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 323 | $1.02K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 323 | $711 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 323 | $1.00K | <0.1% | −2−0.5% | ReducedConverted for a 1-for-15 split | Holders |
| Q2 2022 | 4,870 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 4,870 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 4,870 | $7.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 4,870 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 4,870 | $17.0K | <0.1% | – | No prior filing | Holders |